National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2018 (No. 12) (PB 112 of 2018) (Cth)

PB 112 of 2018

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2018 (No. 12)

National Health Act 1953

___________________________________________________________________________

I, NATASHA PLOENGES, Assistant Secretary (Acting), Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 100(2) of the National Health Act 1953.

Dated   19 December 2018

NATASHA PLOENGES

Assistant Secretary (Acting)

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2018 (No. 12).

(2)This Instrument may also be cited as PB 112 of 2018.

1. Commencement

This Instrument commences on 1 January 2019.

1. Amendment of National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011)

Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

Schedule 1       Amendments

1. Schedule 1, Part 1, entry for Arsenic

omit from the column headed “Responsible Person”: PL        substitute: FF

1. Schedule 1, Part 1, entry for Fluorouracil in the form Injection 500 mg in 10 mL

a)omit:

Hospira Pty Limited PF MP C6266 C6297 D

b)insert in the columns in order indicated, and in alphabetical order for the column headed “Brand”:

DBL Fluorouracil Injection BP PF MP C6266 C6297 D

1. Schedule 3, details relevant to Responsible Person code AE

substitute:

AE AFT Pharmaceuticals (AU) Pty Ltd 29 105 636 413

1. Schedule 3, after details relevant to Responsible Person code FB

insert:

FF Phebra Pty Ltd 99 059 357 890

1. Schedule 3

omit:

PL The Trustee for Virgo Unit Trust (trading as Phebra) 77 695 661 635